Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001)
Yasuo Kitamura,Hidenori Mizugaki,Yasuyuki Ikezawa,Ryo Morita,Kazunari Tateishi,Keiki Yokoo,Toshiyuki Sumi,Hajime Kikuchi,Atsushi Nakamura,Maki Kobayashi,Mari Aso,Nozomu Kimura,Fumiaki Yoshiike,Megumi Furuta,Hisashi Tanaka,Motoki Sekikawa,Tsutomu Hachiya,Keiichi Nakamura,Satoshi Oizumi ANNALS OF ONCOLOGY(2022)
AI 理解论文
溯源树
样例